A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Pigment Cell&Melanoma Research, EarlyView.
Source: Pigment Cell Research - Category: Cytology Authors: Janice M.
Mehnert
,
Ann W.
Silk
,
J. H.
Lee
,
Liesel
Dudek
,
Byeong ‐Seon
Jeong
,
Jiadong
Li
,
Jason M.
Schenkel
,
Evita
Sadimin
,
Michael
Kane
,
Hongxia
Lin
,
Weichung J.
Shih
,
Andrew
Zloza
,
Suzie
Chen
Source Type: research